Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Blau

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|July 29, 1993
Therapy for globin-chain disordersC A Blau
Bailliere'S Clinical Haematology|June 29, 2000
Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesisC A Blau
Progress in Experimental Tumor Research|July 1, 1999
In vivo selection of genetically modified bone marrow cellsC A Blau
Nephron|January 1, 1993
Induction of fetal hemoglobin with erythropoietinC A Blau
Experimental Hematology|September 1, 1996
Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabineT Neff, C A Blau
Current Opinion in Hematology|March 1, 1994
Hemoglobin switching and its clinical implicationsC A Blau, G Stamatoyannopoulos
Nature Medicine|February 1, 1996
Preemptive therapy for genetic diseaseC A Blau, G Stamatoyannopoulos
Blood|April 21, 2001
Pharmacologically regulated cell therapyT Neff, C A Blau
Gene Therapy|March 22, 2008
Using gene transfer to circumvent off-target effectsC P Miller, C A Blau
Blood|February 3, 1998
Stimulating cell proliferation through the pharmacologic activation of c-kitL Jin, H Asano, C A Blau
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|July 29, 1993
Therapy for globin-chain disordersC A Blau
Bailliere'S Clinical Haematology|June 29, 2000
Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesisC A Blau
Progress in Experimental Tumor Research|July 1, 1999
In vivo selection of genetically modified bone marrow cellsC A Blau
Nephron|January 1, 1993
Induction of fetal hemoglobin with erythropoietinC A Blau
Experimental Hematology|September 1, 1996
Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabineT Neff, C A Blau
Current Opinion in Hematology|March 1, 1994
Hemoglobin switching and its clinical implicationsC A Blau, G Stamatoyannopoulos
Nature Medicine|February 1, 1996
Preemptive therapy for genetic diseaseC A Blau, G Stamatoyannopoulos
Blood|April 21, 2001
Pharmacologically regulated cell therapyT Neff, C A Blau
Gene Therapy|March 22, 2008
Using gene transfer to circumvent off-target effectsC P Miller, C A Blau
Blood|February 3, 1998
Stimulating cell proliferation through the pharmacologic activation of c-kitL Jin, H Asano, C A Blau
Pageof 3